To ask the Scottish Government what safeguards it has put in place to ensure that the investment it has made in the (a) research and development and (b) manufacturing in Livingston of Valneva’s inactivated whole virus COVID-19 vaccine, will not be used to fund shareholder pay-outs when the company lists on the New York Stock Exchange. The Scottish Governme...